NMR studies of SARS-CoV-2 accessory proteins
- Funded by Swiss National Science Foundation (SNSF)
- Total publications:3 publications
Grant number: 196256
Grant search
Key facts
Disease
COVID-19Start & end year
20202023Known Financial Commitments (USD)
$499,753.78Funder
Swiss National Science Foundation (SNSF)Principal Investigator
Meier Beat HResearch Location
SwitzerlandLead Research Institution
Laboratorium für Physikalische Chemie D-CHAB ETH ZürichResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
Innovation
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Form and function are one, and deciphering structure provides the fundamentals to interfere with function, as central in the context of infection. We here propose to reveal the structures of a group of proteins which the SARS-CoV-2 virus, causing the current pandemic, carries on a non-essential basis, hence their name: accessory proteins. We concentrate on these proteins for two reasons. First, and most importantly, a significant body of evidence has accumulated that points an accusing finger to the accessory proteins and their contribution to viral fitness through modulating the host response to virus infection. Them being the most varying elements in coronaviruses supports this role, since SARS-CoV-2 carries accessory proteins not observed in other human viruses before. Second, the large majority of accessory proteins are small, and often membrane-interacting. NMR is here the method of choice, and notably solid-state NMR. We will combine NMR with cell-free synthesis of the protein samples, an approach which has the central advantages of producing even complex proteins often in well-folded form, and to allow for fast screening of candidate proteins and conditions. Analysis of the samples is enabled by highest magnetic fields and most recent NMR methodology allowing to analyze as few as 100 micrograms of protein, compatible with the quantities obtained from cell-free synthesis. The two PIs on this proposal have a long-standing collaboration (85 common papers), and are strongly committed since several years to this new approach, particularly also through A. Böckmann being a guest scientist at ETH (2020-2023). They plan to apply it here to SARS-CoV-2 accessory proteins to contribute in the fight against this emerging pathogen.
Publicationslinked via Europe PMC
Last Updated:39 minutes ago
View all publications at Europe PMC